» Articles » PMID: 24079748

MicroRNA/mRNA Profiling and Regulatory Network of Intracranial Aneurysm

Overview
Publisher Biomed Central
Specialty Genetics
Date 2013 Oct 2
PMID 24079748
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intracranial aneurysm (IA) is one of the most lethal forms of cerebrovascular diseases characterized by endothelial dysfunction, vascular smooth muscle cell phenotypic modulation, inflammation and consequently loss of vessel cells and extracellular matrix degradation. Besides environmental factors, genetics seem to be a very important factor in the genesis of this disease. Previous mRNA expression studies revealed a large number of differentially expressed genes between IA and control tissue. However, microRNAs (miRNA), small non-coding RNAs which are post-transcriptional regulators of gene expression, have been barely studied. Studying miRNAs could provide a hypothetical mechanism underlying rupture of IA.

Methods: A microarray study was carried out to determine difference in microRNAs and mRNA between patients' IA tissues and controls. Quantitative RT-PCR assay compared the expression level between two groups (14 IA domes vs. 14 controls) were used for validation. Validated miRNAs were analyzed using Ingenuity Pathway Analysis (IPA) to identify the networks and pathways.

Results: 18 miRNAs were confirmed by qPCR to be robustly down-regulated in 14 ruptured IA patients including hsa-mir-133b, hsa-mir-133a, hsa-mir-1, hsa-mir-143-3p, hsa-mir-145-3p, hsa-mir-145-5p, hsa-mir-455-5p, hsa-mir-143-5p, hsa-mir-23b-3p etc., of which 11 miRNAs are clusters: hsa-mir-1/has-mir-133a, hsa-mir-143/hsa-mir-145, hsa-mir-23b/hsa-mir-24-1, and hsa-mir-29b-2/hsa-mir-29c. 12 predicted functions were generated using IPA which showed significant associations with migration of phagocytes, proliferation of mononuclear leukocytes, cell movement of mononuclear leukocytes, cell movement of smooth muscle cells etc.

Conclusion: These data support common disease mechanisms that may be under miRNA control and provide exciting directions for further investigations aimed at elucidating the miRNA mechanisms and targets that may yield new therapies for IA.

Citing Articles

The Potential Contribution of MyomiRs miR-133a-3p, -133b, and -206 Dysregulation in Cardiovascular Disease Risk.

Crocco P, Montesanto A, La Grotta R, Paparazzo E, Soraci L, Dato S Int J Mol Sci. 2024; 25(23).

PMID: 39684483 PMC: 11641116. DOI: 10.3390/ijms252312772.


The Role of Epigenetics in Brain Aneurysm and Subarachnoid Hemorrhage: A Comprehensive Review.

Fernandez-Perez I, Macias-Gomez A, Suarez-Perez A, Vallverdu-Prats M, Giralt-Steinhauer E, Bojtos L Int J Mol Sci. 2024; 25(6).

PMID: 38542406 PMC: 10970583. DOI: 10.3390/ijms25063433.


The role of MicroRNA as a potential diagnostic and prognostic biomarker for cerebral aneurysms.

Al-Jehani H, Turkistani A, Alrayes M, AlHamid M, AlShamikh A, Al Sadah Z Neurosciences (Riyadh). 2023; 28(4):250-257.

PMID: 37844954 PMC: 10827034. DOI: 10.17712/nsj.2023.4.20230028.


Dysregulated Genes and Signaling Pathways in the Formation and Rupture of Intracranial Aneurysm.

Kumar M, Patel K, Chinnapparaj S, Sharma T, Aggarwal A, Singla N Transl Stroke Res. 2023; 15(5):865-879.

PMID: 37644376 DOI: 10.1007/s12975-023-01178-w.


A Transcriptomic Comparative Study of Cranial Vasculature.

Zhang J, Ryu J, Tirado S, Dickinson L, Abosch A, Aziz-Sultan M Transl Stroke Res. 2023; 15(6):1108-1122.

PMID: 37612482 DOI: 10.1007/s12975-023-01186-w.


References
1.
Rangrez A, Massy Z, Metzinger-Le Meuth V, Metzinger L . miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet. 2011; 4(2):197-205. DOI: 10.1161/CIRCGENETICS.110.958702. View

2.
Van Rooij E, Olson E . MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov. 2012; 11(11):860-72. PMC: 6813819. DOI: 10.1038/nrd3864. View

3.
Xin M, Small E, Sutherland L, Qi X, McAnally J, Plato C . MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 2009; 23(18):2166-78. PMC: 2751981. DOI: 10.1101/gad.1842409. View

4.
Somech R, Lev A, Simon A, Hanna S, Etzioni A . T- and B-cell defects in a novel purine nucleoside phosphorylase mutation. J Allergy Clin Immunol. 2012; 130(2):539-42. DOI: 10.1016/j.jaci.2012.03.038. View

5.
Ewing M, Karper J, Abdul S, de Jong R, Peters H, de Vries M . T-cell co-stimulation by CD28-CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development. Int J Cardiol. 2013; 168(3):1965-74. DOI: 10.1016/j.ijcard.2012.12.085. View